Advances in Endovascular Treatment of Femoropopliteal Arterial Occlusive Disease

Perspectives in Vascular Surgery and Endovascular Therapy

Volumn 18, Issue 4, 2006, Pages 329-341

  Klonaris, Chris ^a   Katsargyris, Athanasios ^a   Giannopoulos, Athanasios ^a   Bastounis, Elias ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

angioplasty; atherectomy; brachytherapy; cryoplasty; endovascular; femoropopliteal artery; laser assisted angioplasty; occlusive disease; stenting

Indexed keywords

BIOMATERIAL;

CLINICAL TRIAL; FEMORAL ARTERY; HUMAN; INSTRUMENTATION; INTIMA; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; REVIEW; STENT; VASCULAR PATENCY; VASCULAR SURGERY;

ARTERIAL OCCLUSIVE DISEASES; CLINICAL TRIALS; COATED MATERIALS, BIOCOMPATIBLE; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; STENTS; TUNICA INTIMA; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 34347224758     PISSN: 15310035     EISSN: None     Source Type: Journal    
DOI: 10.1177/1531003506297953     Document Type: Article

References (107)

1. Hertzer NR. The natural history of peripheral vascular disease. Implications for its management. Circulation. 1991;83: 112-119.
2. McDaniel M.D., Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989;3: 273-277.
3. Long term mortality and its predictors in patients with critical leg ischemia. The I.C.A.I. Group. The Study Group of Critical Chronic Ischemia of the Lower Extremities. Eur J Vasc Endovasc Surg. 1997;14: 91-95.
4. Weitz J.I., Byrne J, Clagett G.P., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94: 3026-3049.
5. Anderson P.L., Gelijns A, Moskowitz A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg. 2004;39: 1200-1208.
6. Nowygrod R, Egorova N, Greco G, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg. 2006;43: 205-216.
7. Nasr M.K., McCarthy R.J., Hardman J, Chalmers A, Horrocks M. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2002; 23: 398-403.
8. Kudo T, Chandra F.A., Kwun W.H., Haas B.T., Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006;44: 304-313.
9. Keeling W.B., Stone P.A., Armstrong P.A., et al. Increasing endovascular intervention for claudication: impact on vascular surgery resident training. J Endovasc Ther. 2006;13: 507-513.
10. Wilson S.E., Wolf G.L., Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients. J Vasc Surg. 1989;9: 1-9.
11. Holm J, Arfvidsson B, Jivegard L, et al. Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg. 1991;5: 517-522.
12. van der Zaag E.S., Legemate D.A., Prins M.H., Reekers J.A., Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg. 2004;28: 132-137.
13. Varty K, Nydahl S, Nasim A, Bolia A, Bell P.R., London JM. Results of surgery and angioplasty for the treatment of chronic severe lower limb ischaemia. Eur J Vasc Endovasc Surg. 1998;16: 159-163.
14. Hynes N, Akhtar Y, Manning B, et al. Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Endovasc Ther. 2004;11: 460-471.
15. participants Bt. Bypass versus angioplasty in severe ischemia of the leg(BASIL): multicentre, randomized controlled trial. Lancet. 2005;366: 1925-1934.
16. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA. 1995;274: 165-171.
17. Dormandy J.A., Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000;31: S1-S296.
18. Parsons R.E., Suggs W.D., Lee J.J., Sanchez L.A., Lyon R.T., Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg. 1998;28: 1066-1071.
19. Golledge J, Ferguson K, Ellis M, et al. Outcome of femoropopliteal angioplasty. Ann Surg. 1999;229: 146-153.
20. Black J.H., 3rd, LaMuraglia G.M., Kwolek C.J., Brewster D.C., Watkins M.T., Cambria RP. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg. 2005;42: 932-939.
21. Murray J.G., Apthorp L.A., Wilkins RA. Long-segment (= 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology. 1995;195: 158-162.
22. Capek P, McLean G.K., Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation.1991;83: I70-I80.
23. Krepel V.M., van Andel G.J., van Erp W.F., Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology. 1985;156: 325-332
24. Clark T.W., Groffsky J.L., Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol. 2001; 12: 923-993.
25. Alback A, Biancari F, Schmidt S, et al. Haemodynamic results of femoropopliteal percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 1998;16: 7-12.
26. Crawford D.W., Barndt R., Jr., Back LH. Surface characteristics of normal and atherosclerotic human arteries including observations suggesting interaction between flow and intimal morphology. Lab Invest. 1976;34: 463-540.
27. Davies P.F., Polacek D.C., Shi C, Helmke BP. The convergence of haemodynamics, genomics, and endothelial structure in studies of the focal origin of atherosclerosis. Biorheology. 2002;39: 299-306.
28. Machan L. Drug eluting stents in the infrainguinal circulation. Tech Vasc Interv Radiol. 2004;7: 28-32.
29. Surowiec S.M., Davies M.G., Eberly S.W., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2005;41: 269-278.
30. Kudo T, Chandra F.A., Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005;41: 423-435; discussion 435.
31. Goshima K.R., Mills J.L., Sr., Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg. 2004;39: 330-335.
32. Vroegindeweij D, Vos L.D., Tielbeek A.V., Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol. 1997;20: 420-425.
33. Zdanowski Z, Albrechtsson U, Lundin A, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18: 251-255.
34. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12: 23-31.
35. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12: 935-942.
36. Becquemin J.P., Favre J.P., Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37: 487-494.
37. Grenacher L, Saam T, Geier A, et al. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)]. Rofo. 2004;176: 1302-1310.
38. Muradin G.S., Bosch J.L., Stijnen T, Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001; 221: 137-145.
39. Henry M, Henry I, Klonaris C, Hugel M. Clinical experience with the OptiMed sinus stent in the peripheral arteries. J Endovasc Ther. 2003;10: 772-779.
40. Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol. 2002; 13: 257-266.
41. Vogel T.R., Shindelman L.E., Nackman G.B., Graham AM. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg. 2003;38: 1178-1184.
42. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol. 2004;7: 2-5.
43. Lugmayr H.F., Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology. 2002;222: 37-43.
44. Hayerizadeh R Z.T., Krankenberg H. Long-term outcome of superficial femoral artery stenting using nitinol stents compared with stainless steel stents. A multicenter study. Am J Cardiol. 2003;92(Suppl): S157L-S157L.
45. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232: 516-521.
46. Duda S.H., Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106: 1505-1509.
47. Duda S.H., Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16: 331-338.
48. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354: 1879-1888.
49. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45: 312-315.
50. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting—the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12: 676-684.
51. Cheng S.W., Ting A.C., Wong J. Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg. 2001;9: 133-140.
52. Bolia A, Miles K.A., Brennan J, Bell PR. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990;13: 357-363.
53. London N.J., Srinivasan R, Naylor A.R., et al. Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg. 1994;8: 148-155.
54. Hynes N, Mahendran B, Manning B, Andrews E, Courtney D, Sultan S. The influence of subintimal angioplasty on level of amputation and limb salvage rates in lower limb critical ischaemia: a 15-year experience. Eur J Vasc Endovasc Surg. 2005;30: 291-299.
55. Lipsitz E.C., Ohki T, Veith F.J., et al. Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg. 2003;37: 386-391.
56. Smith B.M., Stechman M, Gibson M, Torrie E.P., Magee T.R., Galland RB. Subintimal angioplasty for superficial femoral artery occlusion: poor patency in critical ischaemia. Ann R Coll Surg Engl. 2005;87: 361-365.
57. Kim J.S., Kang T.S., Ahn C.M., et al. Efficacy of subintimal angioplasty/stent implantation for long, multisegmental lower limb occlusive lesions in patients unsuitable for surgery. J Endovasc Ther. 2006;13: 514-521.
58. Reekers JA. Percutaneous intentional extraluminal (subintimal) revascularization (PIER) for critical lower limb ischemia: too good to be true? J Endovasc Ther. 2002; 9: 419-421.
59. Yilmaz S, Sindel T, Yegin A, Luleci E. Subintimal angioplasty of long superficial femoral artery occlusions. J Vasc Interv Radiol. 2003;14: 997-1010.
60. Treiman G.S., Treiman R, Whiting J. Results of percutaneous subintimal angioplasty using routine stenting. J Vasc Surg. 2006;43: 513-519.
61. Walker S.R., Papavassiliou V.G., Bolia A, London N. Subintimal angioplasty of native vessels in the management of occluded vascular grafts. Eur J Vasc Endovasc Surg. 2001;22: 41-43.
62. Hausegger K.A., Georgieva B, Portugaller H, Tauss J, Stark G. The outback catheter: a new device for true lumen re-entry after dissection during recanalization of arterial occlusions. Cardiovasc Intervent Radiol. 2004;27: 26-30.
63. Jacobs D.L., Motaganahalli R.L., Cox D.E., Wittgen C.M., Peterson GJ. True lumen re-entry devices facilitate subintimal angioplasty and stenting of total chronic occlusions: Initial report. J Vasc Surg. 2006;43: 1291-1296.
64. Balas P, Pangratis N, Ioannou N, Milas P, Klonaris C, Masouridou E. Open subintimal angioplasty of the superficial femoral and distal arteries. J Endovasc Ther. 2000;7: 68-71.
65. Henry M, Amor M, Cragg A, et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology. 1996;201: 717-724.
66. Cragg A.H., Dake MD. Treatment of peripheral vascular disease with stent-grafts. Radiology. 1997;205: 307-314.
67. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology. 2002;223: 345-350.
68. Marin M.L., Veith F.J., Cynamon J, et al. Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg. 1995; 21: 595-603; discussion 603-604.
69. Virmani R, Kolodgie F.D., Dake M.D., et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol. 1999;10: 445-456.
70. Lammer J, Dake M.D., Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217: 95-104.
71. Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther. 2006;13: 281-290.
72. Saxon R.R., Coffman J.M., Gooding J.M., Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14: 303-311.
73. Saxon R.R., Coffman J.M., Gooding J.M., Ponec DJ. Endograft use in the femoral and popliteal arteries. Tech Vasc Interv Radiol. 2004;7: 6-15.
74. Hartung O, Otero A, Dubuc M, et al. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg. 2005;30: 300-306.
75. Wiesinger B, Beregi J.P., Oliva V.L., et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study. J Endovasc Ther. 2005; 12: 240-246.
76. Deutschmann H.A., Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol. 2001;12: 943-950.
77. Ansel G.M., Botti C.F., Jr., Silver MJ. The use of femoropopliteal stent-grafts for critical limb ischemia. Tech Vasc Interv Radiol. 2005;8: 140-145.
78. Mewissen MW. Stenting in the femoropopliteal arterial segment. Tech Vasc Interv Radiol. 2005;8: 146-149.
79. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349: 1315-1323.
80. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348: 1537-1545.
81. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102: 2694-2699.
82. Pokrajac B, Potter R, Wolfram R.M., et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multi-center study. Radiother Oncol. 2005;74: 3-9.
83. Diehm N, Silvestro A, Do D.D., et al. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J Endovasc Ther. 2005;12: 723-730.
84. Wolfram R.M., Budinsky A.C., Pokrajac B, Potter R, Minar E. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up—prospective randomized study. Radiology. 2006;240: 878-884.
85. Krueger K, Zaehringer M, Bendel M, et al. De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty—angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology. 2004;231: 546-554.
86. Wolfram R.M., Budinsky A.C., Pokrajac B, Potter R, Minar E. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology. 2005;236: 343-351.
87. Wyttenbach R, Gallino A, Alerci M, et al. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 2004;110: 1156-1161.
88. Tatsutani K.N., Joye J.D., Virmani R, Taylor MJ. In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing. Cryo Lett. 2005;26: 55-64.
89. Laird J, Jaff M.R., Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol. 2005;16: 1067-1073.
90. Laird J.R., Biamino G, McNamara T, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results. J Endovasc Ther. 2006;13(Suppl 2): II52-II59.
91. Bittl JA. Clinical results with excimer laser coronary angioplasty. Semin Interv Cardiol. 1996;1: 129-134.
92. Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators. J Am Coll Cardiol. 1994;23: 323-329.
93. Lammer J, Pilger E, Decrinis M, Quehenberger F, Klein G.E., Stark G. Pulsed excimer laser versus continuous-wave Nd: YAG laser versus conventional angioplasty of peripheral arterial occlusions: prospective, controlled, randomised trial. Lancet. 1992;340: 1183-1188.
94. Biamino G. The excimer laser: science fiction fantasy or practical tool? J Endovasc Ther. 2004;11(Suppl 2): II207-II222.
95. Das TS. Percutaneous peripheral revascularisation with excimer laser: equipment, technique and results. Lasers Med Sci. 2001;16: 101-107.
96. Boccalandro F, Muench A, Sdringola S, Rosales OR. Wireless laser-assisted angioplasty of the superficial femoral artery in patients with critical limb ischemia who have failed conventional percutaneous revascularization. Catheter Cardiovasc Interv. 2004;63: 7-12.
97. Laird J.R., Zeller T, Gray B.H., et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13: 1-11.
98. Bosiers M, Peeters P, Elst F.V., et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg. 2005;29: 613-619.
99. Tcheng J.E., Volkert-Noethen AA. Current multicentre studies with the excimer laser: design and aims. Lasers Med Sci. 2001;16: 122-129.
100. Steinkamp H.J., Rademaker J, Wissgott C, et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther. 2002;9: 882-888.
101. Moussa I, Moses J, Di Mario C, et al. Stenting after optimal lesion debulking (sold) registry. Angiographic and clinical outcome. Circulation. 1998;98: 1604-1609.
102. Bramucci E, Angoli L, Merlini P.A., et al. Adjunctive stent implantation following directional coronary atherectomy in patients with coronary artery disease. J Am Coll Cardiol. 1998;32: 1855-1860.
103. Wildenhain P.M., Wholey M.H., Jarmolowski C.R., Hill KL. Infrainguinal directional atherectomy: long-term follow-up and comparison with percutaneous transluminal angioplasty. Cardiovasc Intervent Radiol. 1994;17: 305-311.
104. Tielbeek A.V., Vroegindeweij D, Buth J, Landman GH. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol. 1996;7: 837-844.
105. Kolvenbach R, Strosche H. Long term results after rotation angioplasty and catheter atherectomy. A retrospective analysis. J Cardiovasc Surg (Torino). 1998;39: 15-18.
106. Zeller T, Rastan A, Schwarzwalder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther. 2004;11: 676-685.
107. Gammon R. Plaque excision treatment of infrainguinal PAD. Endovasc Today. 2005;6: 70-74.